Shanghai Shen Lian Biomedical Corp
SSE:688098
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shanghai Shen Lian Biomedical Corp
SSE:688098
|
CN |
|
T
|
True Partner Capital Holding Ltd
HKEX:8657
|
HK |
|
H
|
Hallmark Financial Services Inc
XBER:SSB
|
US |
|
S
|
Shukra Pharmaceuticals Ltd
BSE:524632
|
IN |
|
G
|
General Mills Inc
XETRA:GRM
|
US |
|
Paycor HCM Inc
NASDAQ:PYCR
|
US |
|
Qingdao Richen Food Co Ltd
SSE:603755
|
CN |
|
Sonos Inc
NASDAQ:SONO
|
US |
|
B
|
Bleach Inc
TSE:9162
|
JP |
|
Daifuku Co Ltd
TSE:6383
|
JP |
|
C
|
Carzo Holdings Bhd
KLSE:CARZO
|
MY |
|
Medley Inc
TSE:4480
|
JP |
|
Kawata Mfg. Co Ltd
TSE:6292
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Shanghai Shen Lian Biomedical Corp's stock price target?
Not Available
Shanghai Shen Lian Biomedical Corp doesn't have any price targets made by Wall Street professionals.
What is Shanghai Shen Lian Biomedical Corp's Revenue forecast?
Projected CAGR
119%
For the last 7 years the
compound annual growth rate for
Shanghai Shen Lian Biomedical Corp's revenue is
0%.
The projected
CAGR
for the next 1 year is
119%.